Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma
- Author
- SCHMIDT-HIEBER, M1 ; BLAU, I. W1 ; FAUSER, A. A6 ; VOLIN, L7 ; RUUTU, T7 ; UHAREK, L1 ; FIETZ, T8 ; KNAUF, W9 ; HOPFENMÜLLER, W10 ; THIEL, E1 ; FREUND, M11 ; CASPER, J11 ; TRENSCHEL, R2 ; ANDREESEN, R3 ; STUHLER, G4 ; EINSELE, H4 ; KANZ, L5 ; KEILHOLZ, U1 ; MARINETS, O1 ; BEELEN, D. W2
[1] Medizinische Klinik III (Hämatologie, Onkologie und Transfusionsmedizin), Charité -Campus Benjamin Franklin, Berlin, Germany
[2] Klinik für Knochenmarktransplantation, Universitätsklinikum Essen, Essen, Germany
[3] Abteilung für Hämatologie und Onkologie, Klinikum der Universität Regensburg, Regensburg, Germany
[4] Medizinische Klinik und Poliklinik II, Universitätsklinikum Würzburg, Würzburg, Germany
[5] Medizinische Klinik II, Universitätsklinikum Tübingen, Tübingen, Germany
[6] Klinik für Knochenmarktransplantation und Hämatologie/Onkologie GmbH, Idar-Oberstein, Germany
[7] Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
[8] Onkologische Schwerpunkpraxis, Singen, Germany
[9] Onkologische Schwerpunktpraxis Bethanien, Frankfurt/Main, Germany
[10] Institut für medizinische Statistik, Charité -Campus Benjamin Franklin, Berlin, Germany
[11] Abteilung für Hämatologie und Onkologie, Klinik und Poliklinik für Innere Medizin der Universität Rostock, Rostock, Germany - Source
Bone marrow transplantation (Basingstoke). 2007, Vol 39, Num 7, pp 389-396, 8 p ; ref : 47 ref
- CODEN
- BMTRE9
- ISSN
- 0268-3369
- Scientific domain
- Medical oncology; Graft, transplantation; Hematology
- Publisher
- Nature Publishing Group, Basingstoke
- Publication country
- United Kingdom
- Document type
- Article
- Language
- English
- Author keyword
- SCT fludarabine multiple myeloma reduced-toxicity conditioning treosulfan
- Keyword (fr)
- Anticancéreux Cellule hématopoïétique Cellule souche Conditionnement Fludarabine Homogreffe Hématologie Myélome Toxicité Tréosulfan Analogue nucléotide Acide alcanesulfonique Agent alkylant Alcanediol Antimétabolite Fluor Composé organique Greffe Hémopathie maligne Immunoglobulinopathie Immunopathologie Lymphoprolifératif syndrome Purine nucléotide
- Keyword (en)
- Antineoplastic agent Hematopoietic cell Stem cell Conditioning Fludarabine Homograft Hematology Myeloma Toxicity Treosulfan Alkanesulfonic acid Alkylating agent Alkanediol Antimetabolic Fluorine Organic compounds Graft Malignant hemopathy Immunoglobulinopathy Immunopathology Lymphoproliferative syndrome Purine nucleotide
- Keyword (es)
- Anticanceroso Célula hematopoyética Célula primitiva Acondicionamiento Fludarabina Homoinjerto Hematología Mieloma Toxicidad Treosulfano Acido alcanosulfónico Agente alquilante Alcanodiol Antimetabólito Fluor Compuesto orgánico Injerto Hemopatía maligna Inmunoglobulinopatía Inmunopatología Linfoproliferativo síndrome Purina nucleótido
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D02 Immunoglobulinopathies
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27D Transfusions. Complications. Transfusion reactions. Cell and gene therapy / 002B27D02 Bone marrow, stem cells transplantation. Graft versus host reaction
- Discipline
- Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Immunopathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18665526
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1038/sj.bmt.1705605 
https://dx.doi.org/10.1038/sj.bmt.1705605
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705605\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"389\";s:8:\"\u0000*\u0000epage\";s:3:\"396\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SCHMIDT-HIEBER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:10:\"BLAU, I. W\";i:1;s:12:\"FAUSER, A. A\";i:2;s:8:\"VOLIN, L\";i:3;s:8:\"RUUTU, T\";i:4;s:9:\"UHAREK, L\";i:5;s:8:\"FIETZ, T\";i:6;s:8:\"KNAUF, W\";i:7;s:16:\"HOPFENM\u00dcLLER, W\";i:8;s:8:\"THIEL, E\";i:9;s:9:\"FREUND, M\";i:10;s:9:\"CASPER, J\";i:11;s:12:\"TRENSCHEL, R\";i:12;s:12:\"ANDREESEN, R\";i:13;s:10:\"STUHLER, G\";i:14;s:10:\"EINSELE, H\";i:15;s:7:\"KANZ, L\";i:16;s:11:\"KEILHOLZ, U\";i:17;s:11:\"MARINETS, O\";i:18;s:12:\"BEELEN, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705605\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"389\";s:8:\"\u0000*\u0000epage\";s:3:\"396\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SCHMIDT-HIEBER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:10:\"BLAU, I. W\";i:1;s:12:\"FAUSER, A. A\";i:2;s:8:\"VOLIN, L\";i:3;s:8:\"RUUTU, T\";i:4;s:9:\"UHAREK, L\";i:5;s:8:\"FIETZ, T\";i:6;s:8:\"KNAUF, W\";i:7;s:16:\"HOPFENM\u00dcLLER, W\";i:8;s:8:\"THIEL, E\";i:9;s:9:\"FREUND, M\";i:10;s:9:\"CASPER, J\";i:11;s:12:\"TRENSCHEL, R\";i:12;s:12:\"ANDREESEN, R\";i:13;s:10:\"STUHLER, G\";i:14;s:10:\"EINSELE, H\";i:15;s:7:\"KANZ, L\";i:16;s:11:\"KEILHOLZ, U\";i:17;s:11:\"MARINETS, O\";i:18;s:12:\"BEELEN, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705605\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705605\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"389\";s:8:\"\u0000*\u0000epage\";s:3:\"396\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SCHMIDT-HIEBER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:10:\"BLAU, I. W\";i:1;s:12:\"FAUSER, A. A\";i:2;s:8:\"VOLIN, L\";i:3;s:8:\"RUUTU, T\";i:4;s:9:\"UHAREK, L\";i:5;s:8:\"FIETZ, T\";i:6;s:8:\"KNAUF, W\";i:7;s:16:\"HOPFENM\u00dcLLER, W\";i:8;s:8:\"THIEL, E\";i:9;s:9:\"FREUND, M\";i:10;s:9:\"CASPER, J\";i:11;s:12:\"TRENSCHEL, R\";i:12;s:12:\"ANDREESEN, R\";i:13;s:10:\"STUHLER, G\";i:14;s:10:\"EINSELE, H\";i:15;s:7:\"KANZ, L\";i:16;s:11:\"KEILHOLZ, U\";i:17;s:11:\"MARINETS, O\";i:18;s:12:\"BEELEN, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705605\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"389\";s:8:\"\u0000*\u0000epage\";s:3:\"396\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SCHMIDT-HIEBER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:10:\"BLAU, I. W\";i:1;s:12:\"FAUSER, A. A\";i:2;s:8:\"VOLIN, L\";i:3;s:8:\"RUUTU, T\";i:4;s:9:\"UHAREK, L\";i:5;s:8:\"FIETZ, T\";i:6;s:8:\"KNAUF, W\";i:7;s:16:\"HOPFENM\u00dcLLER, W\";i:8;s:8:\"THIEL, E\";i:9;s:9:\"FREUND, M\";i:10;s:9:\"CASPER, J\";i:11;s:12:\"TRENSCHEL, R\";i:12;s:12:\"ANDREESEN, R\";i:13;s:10:\"STUHLER, G\";i:14;s:10:\"EINSELE, H\";i:15;s:7:\"KANZ, L\";i:16;s:11:\"KEILHOLZ, U\";i:17;s:11:\"MARINETS, O\";i:18;s:12:\"BEELEN, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:22:\"10.1038\/sj.bmt.1705605\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:9:\"\u0000*\u0000jtitle\";s:41:\"Bone marrow transplantation (Basingstoke)\";s:9:\"\u0000*\u0000stitle\";s:37:\"Bone marrow transplant. (Basingstoke)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"39\";s:8:\"\u0000*\u0000issue\";s:1:\"7\";s:8:\"\u0000*\u0000spage\";s:3:\"389\";s:8:\"\u0000*\u0000epage\";s:3:\"396\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0268-3369\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:14:\"SCHMIDT-HIEBER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:19:{i:0;s:10:\"BLAU, I. W\";i:1;s:12:\"FAUSER, A. A\";i:2;s:8:\"VOLIN, L\";i:3;s:8:\"RUUTU, T\";i:4;s:9:\"UHAREK, L\";i:5;s:8:\"FIETZ, T\";i:6;s:8:\"KNAUF, W\";i:7;s:16:\"HOPFENM\u00dcLLER, W\";i:8;s:8:\"THIEL, E\";i:9;s:9:\"FREUND, M\";i:10;s:9:\"CASPER, J\";i:11;s:12:\"TRENSCHEL, R\";i:12;s:12:\"ANDREESEN, R\";i:13;s:10:\"STUHLER, G\";i:14;s:10:\"EINSELE, H\";i:15;s:7:\"KANZ, L\";i:16;s:11:\"KEILHOLZ, U\";i:17;s:11:\"MARINETS, O\";i:18;s:12:\"BEELEN, D. W\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"BMTRE9\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:127:\"Reduced-toxicity conditioning with fludarabine and treosulfan prior to allogeneic stem cell transplantation in multiple myeloma\";s:8:\"\u0000*\u0000place\";s:11:\"Basingstoke\";s:6:\"\u0000*\u0000pub\";s:23:\"Nature Publishing Group\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:1:\"8\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
